- CA$2.33bn
- CA$2.65bn
- CA$772.84m
- 88
- 19
- 77
- 65
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 526 | 561 | 625 | 735 | 773 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 486 | 517 | 585 | 724 | 725 |
Operating Profit | 40.1 | 44.2 | 40.5 | 11.1 | 47.4 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 30.8 | 37.6 | 34.2 | 3.88 | 22.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 23.9 | 27 | 25.6 | -0.889 | 10.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 18.2 | 21.4 | 25.7 | -0.886 | 10.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 18.2 | 21.4 | 25.7 | -0.886 | 10.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.653 | 0.882 | 0.805 | 0.801 | 0.407 |
Dividends per Share |